N01AB06 - Isoflurane |
Propably not porphyrinogenic |
PNP |
Rationale
Isoflurane has a low hepatic metabolism, it is not metabolised by the most abundant CYP isoenzymes, 3A4 and 2C9. Probably insignificant metabolism by CYP 2E1. Possible inducer of hepatic CYP 2B6. There are both preclinical and clinical experience pointing to non-porphyrogenicity.
Chemical description
1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether; 2-Chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane. M= 184.5. Halogenated ethyl methylether used in inhalation anesthesia, isomer to enflurane. Volatile, boiling point of 48 degree celcius.
Therapeutic characteristics
Inhalation anestethic. It is used in the induction and maintenance of general anaesthesia although induction is more often carried out using an intravenous anaesthetic. Isoflurane is also used in subanaesthetic doses to provide analgesia in obstetrics and other painful procedures.
Hepatic exposure
As for all inhalation anesthetics the hepatic exposure will be sufficient enough to affect the porphyria status of the patient.
Metabolism and pharmakokinetics
About 95% is eliminated by the lungs. About 0.2% of inhaled isoflurane is metabolised, mainly to inorganic fluoride. Isoflurane is metabolised by the 2B6 and 2E1 isoforms, it is an activator for the 2B6 isoform.
Preclinical data
Isoflurane causes no increase in ALAS activity in rats (Parikh, et al. 1978).
Personal communication
In Sweden it is repeatedly observed not to cause porphyric side effects.
Published experience
There are several reports of safe use of isoflurane in patients with porphyria. (Kantor G, et al. 1992),(Lin YC, et al. 1990),(McLouglin C 1989).
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
References
- Scientific articles
- Böhrer H, et al. Leitlinie zur durchführung von anästhesien bei patienten mit porphyrie. Anästhesiologie & intensivmedizin 2002;43:485-9. #2417
- Kantor G, et al. Acute intermittent porphyria and caesarean delivery. Can J Anaesth. 1992;39(3):282-5. PMID 1551161. #4633
- Lin YC, et al. Atracurium in a patient with acute intermittent porphyria. Anesth Analg. 1990;71(4):440-1. #3716
- McLouglin C. Use of propofol in a patient with porphyria. Br J Anaesth. 1989;62(1):114. #3717
- Parikh RK, et al. Effect of certain anaesthetic agents on the activity of rat hepatic delta-aminolaevulinate synthase. Br J Anaesth 1978;50:1099-1103. PMID 718778. #4632
- Rendic S. Summary of information on human CYP enzymes: Human p450 metabolism data. Drug Metab Rev. 2002;34(1-2):83-448. PMID 11996015. #3718
- Drug reference publications
- Sweetman S (ed), Martindale: The Complete drug reference. Isoflurane Monography. London: Pharmaceutical Press. Electronic version. (read 27. may 2008). #3719
Similar drugs
© NAPOS 2024